Search for: "In Re Ouellette"
Results 41 - 60
of 71
Sorted by Relevance
|
Sort by Date
3 Mar 2022, 6:43 am
The fact remains, though, that likely millions of people in the U.S. alone will continue to report a variety of challenging symptoms more than 6 months after they’re infected. [read post]
6 Oct 2014, 5:36 am
At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
23 Jan 2024, 11:32 am
"Another way software is different is because software involves creating computer code that can be re-used for other purposes. [read post]
12 Apr 2013, 9:14 am
Eric Goldman: Lisa Ouellette wrote a paper on using Google to confirm strength of a mark. [read post]
9 Sep 2016, 2:34 pm
Discussion leaders: Lisa Ouellette: Accounts indicate that non-incentive reasons drive much patenting, contrary to standard incentive story. [read post]
13 Dec 2010, 10:37 am
I'm sure you're shocked to learn that Microsoft weighed in with a brief against YouTube. [read post]
12 May 2018, 9:54 am
If you’re a 512(f) enthusiast, you know better than to get too excited about this ruling. [read post]
26 May 2011, 10:58 pm
No problem it seems for Google’s music locker (IP Osgoode) ICE seizes more domains today, admin says ‘We’ll be back’ (TorrentFreak) (TorrentFreak) ‘Hi, my name is…Slim Shady’ and your ringtone is a licence (IP Whiteboard) US Copyright – Decisions District Court Montana: Another ruling that the Americans with Disabilities Act doesn’t apply to websites: Ouellette v. [read post]
1 Feb 2022, 6:48 am
Durvasula, Lisa Larrimore Ouellette, and Heidi L. [read post]
20 Jan 2015, 10:06 am
As Professor Ouellette wrote this morning: “Today’s opinion joins a long line of Supreme Court decisions rebuking the Federal Circuit for patent law exceptionalism. [read post]
22 Aug 2020, 8:21 am
Universal Music * 512(f) Plaintiff Can’t Get Discovery to Back Up His Allegations of Bogus Takedowns–Ouellette v. [read post]
1 Sep 2015, 3:52 am
Bars to re-litigation of indefiniteness: Nova’s challenge faced a substantial procedural hurdle, however. [read post]
4 Mar 2021, 10:50 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsAre patents the cause of—or solution to—COVID-19 vaccine innovation problems? [read post]
30 Mar 2020, 8:40 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOne of the dizzying stream of innovation and health law stories to emerge last week is Oracle’s partnership with the White House to study unproven pharmaceuticals for treating COVID-19. [read post]
13 Aug 2020, 8:09 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn this blog post series, we have written about the importance of ensuring an adequate supply of diagnostic testing for COVID-19, and about the challenges the United States has faced so far on this front. [read post]
12 Jan 2021, 9:04 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
16 Aug 2019, 6:32 am
To receive maximum points in the economic benefits category, suppliers have to provide contractual guarantees that they will re-invest the “value of their proposed contract” in Canadian industry. [read post]
9 Sep 2016, 5:02 pm
But most people think they’re consistent w/law. [read post]
